Intranasal administration of Ganoderma lucidum-derived exosome-like nanovesicles ameliorates cognitive impairment by reducing inflammation in a mouse model of Alzheimer’s disease

Background/ObjectivesAlthough Alzheimer’s disease (AD) is the most prevalent dementia in late life, with amyloid beta (Aβ) deposition and neuroinflammation are recognized among its primary pathological features. Currently, there is currently still a lack of effective therapeutic drugs for AD. Ganode...

Descripción completa

Detalles Bibliográficos

Autores principales:	Xue Mi, Xinglin Ruan, Renyi Lin, Shuxin Huang, Ping Cai, Xiaochun Chen, Jiangfeng Liao, Xiaoman Dai
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2025-07-01
Colección:	Frontiers in Pharmacology
Materias:	Ganoderma. lucidum (G. lucidum)-derived exosome-like nanovesicles cognitive impairment inflammatory response Alzheimer’s disease intranasal administration
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1572771/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!